Skip to content

Safety and feasibility study of fetal cardiac intervention for critical aortic stenosis

Safety and feasibility study of fetal cardiac intervention for critical aortic stenosis - Feasibility study of fetal intervention for critical aortic stenosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036649
Enrollment
5
Registered
2019-05-08
Start date
2019-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critical aortic stenosis

Interventions

Fetal aortic valvuloplasty for critical aortic stenosis

Sponsors

Japanese Society of Fetal Cardiology
Lead Sponsor
The Japan Society of Fetal Therapy Japanese Society of Pediatric Cardiology and Cardiac Surgery
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: [Maternal criteria] Between 22+0 and 31+6 weeks gestation Pregnant women who have no severe complication or symptom of preterm labor [Fetal criteria] Fetal critical aortic stenosis without small left ventricle Z score of LV long-axis dimension >-2 Threshold score 4 or 5 No other severe anomalies

Exclusion criteria

Exclusion criteria: Pregnant women who have infectious diseases required treatments Pregnant women who have severe psychological disorder American Society of Anesthesiology (ASA) Physical Status Classification Class 3, 4, 5 or 6 Multiple pregnancy Severe obesity (BMI >35)

Design outcomes

Primary

MeasureTime frame
The rates of completing protocol therapy without severe adverse events

Secondary

MeasureTime frame
The number and grade of adverse events by protocol therapy

Countries

Japan

Contacts

Public ContactSeiji Wada

National Center for Child Health and Development Division of Fetal Medicine

wada-s@ncchd.go.jp03-3416-0181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026